Five Prime Therapeutics, Inc. Product Trends & Analysis - 2015 - PowerPoint PPT Presentation

Loading...

PPT – Five Prime Therapeutics, Inc. Product Trends & Analysis - 2015 PowerPoint presentation | free to download - id: 7ebb48-ZWVmM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Five Prime Therapeutics, Inc. Product Trends & Analysis - 2015

Description:

Global Markets Directs, Five Prime Therapeutics, Inc.Product Pipeline Review - 2015, provides an overview of the Five Prime Therapeutics, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ – PowerPoint PPT presentation

Number of Views:13

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Five Prime Therapeutics, Inc. Product Trends & Analysis - 2015


1
Five Prime Therapeutics, Inc. Product Pipeline
Review - 2015
No. Pages 44
Published on October - 2015
2
.
Report Overview
About Five Prime Therapeutics, Inc.Product
Pipeline Review - 2015 Global Markets Directs,
Five Prime Therapeutics, Inc.Product Pipeline
Review - 2015, provides an overview of the Five
Prime Therapeutics, Inc.s pharmaceutical research
and development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of Five Prime
Therapeutics, Inc.s, complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. It also reviews latest updates, and
featured news and press releases, along with
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/five
-prime-therapeutics-inc-product-pipeline-review-20
15-market
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Five Prime Therapeutics,
Inc.including business description, key
information and facts, and its locations and
subsidiaries The report reviews current pipeline
of Five Prime Therapeutics, Inc.s human
therapeutic division and enlists all their major
and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Five Prime Therapeutics, Inc.s pipeline
products   Reasons to buy Evaluate Five Prime
Therapeutics, Inc.s strategic position with total
access to detailed information on its product
pipeline Assess the growth potential of Five
Prime Therapeutics, Inc.in its therapy areas of
focus Identify new drug targets and therapeutic
classes in the Five Prime Therapeutics, Inc.s RD
portfolio and develop key strategic initiatives
to reinforce pipeline in those areas Exploit
in-licensing opportunities by identifying windows
of opportunity to fill portfolio gaps
5
Report Overview
  • Develop strategic initiatives by understanding
    the focus areas of Five Prime Therapeutics,
    Inc.and exploit collaboration and partnership
    opportunities
  • Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by
    identifying the most promising pipeline of Five
    Prime Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope
  • Explore the dormant and discontinued projects of
    Five Prime Therapeutics, Inc.and identify
    potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4 List of Figures 4 Five Prime
Therapeutics, Inc. Snapshot 5 Five Prime
Therapeutics, Inc. Overview 5 Key Information
5 Key Facts 5 Five Prime Therapeutics, Inc. -
Research and Development Overview 6 Key
Therapeutic Areas 6 Five Prime Therapeutics, Inc.
- Pipeline Review 8 Pipeline Products by Stage of
Development 8 Pipeline Products - Monotherapy
9 Pipeline Products - Partnered Products
10 Partnered Products/Combination Treatment
Modalities 11 Pipeline Products - Out-Licensed
Products 12
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 13 Five Prime Therapeutics, Inc. -
Pipeline Products Glance 14 Five Prime
Therapeutics, Inc. - Clinical Stage Pipeline
Products 14 Phase I Products/Combination
Treatment Modalities 14 Five Prime Therapeutics,
Inc. - Early Stage Pipeline Products
15 Preclinical Products/Combination Treatment
Modalities 15 Discovery Products/Combination
Treatment Modalities 16 Five Prime Therapeutics,
Inc. - Drug Profiles 17 FPA-008 17 Product
Description 17 Mechanism of Action 17 RD
Progress 17
8
Table Of Contents
FP-1039 19 Product Description 19 Mechanism of
Action 19 RD Progress 19 FPA-144 21 Product
Description 21 Mechanism of Action 21 RD
Progress 21 INBRX-110 23 Product Description
23 Mechanism of Action 23 RD Progress 23 Enquiry
about this report _at_ http//www.researchbeam.com/fi
ve-prime-therapeutics-inc-product-pipeline-review-
2015-market/enquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/five-prime-therapeutic
s-inc-product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States
TELEPHONE 1 (800) 910-6452 E-MAIL
sales_at_researchbeam.com
About PowerShow.com